[1]
“Clinical audit on treatment of mucosal and multiple cutaneous leishmaniasis lesions with pentavalent systemic antimony”, J Pak Assoc Dermatol, vol. 25, no. 1, pp. 40–43, Nov. 2016, doi: 10.66344/jpad.v25i1.128.